-
Miracle supplement linked to better memory in middle age and a 30 percent reduction in Alzheimer's risk
20 Apr 2024 07:27 GMT
When it comes to optimising your brain health, there's no one-size-fits-all solution: the organ is simply too complex for that.
However, supplements are increasingly viewed as an essential piece of the puzzle.
One of the most promising is …
-
Pendleton man coping with Alzheimer's disease considers end of life options
18 Apr 2024 16:00 GMT
Andrew and Barbara Clark are grappling with what it means to grow old as a couple while facing the added burden of Andrew’s Alzheimer’s disease diagnosis.
Andrew, 83, was diagnosed with mild cognitive impairment in 2019. His impairment has since been …
-
Alzheimer's Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032
18 Apr 2024 15:00 GMT
Ottawa, April 18, 2024 (GLOBE NEWSWIRE) -- The global alzheimer's therapeutics market size was valued at USD 4.82 billion in 2023 and is predicted to hit around USD 7.52 billion by 2031, a study published by Towards Healthcare a sister firm of …
-
Could a simple eye test predict Alzheimer's 12 years before symptoms…
18 Apr 2024 14:08 GMT
Vision problems can be an early sign of Alzheimer’s disease.
Researchers from Loughborough University in the United Kingdom argue that a loss of visual sensitivity can predict Alzheimer’s disease 12 years before diagnosis.
Scientists suggest combining …
-
Vision Test May Be Able To Reveal Dementia Risk 12 Years In Advance: Study
18 Apr 2024 08:18 GMT
Vision Test May Be Able To Reveal Dementia Risk 12 Years In Advance: Study (Image Credits: iStock)
A recent study has revealed that the condition of our eyes can provide significant insights into brain health. Published in the US National Library of …
-
Renowned Alzheimer's Neurologist Dale Bredesen, MD, Joins Pacific Neuroscience Institute
17 Apr 2024 15:29 GMT
He Believes That Alzheimer's Disease is Becoming Optional
SANTA MONICA, Calif., April 16, 2024 /PRNewswire/ -- Pacific Neuroscience Institute® (PNI) is thrilled to announce that Dale Bredesen, MD, has joined Pacific Neuroscience Institute®. …
-
Promising research for slowing Alzheimer's disease — and more
16 Apr 2024 21:34 GMT
Medical Watch Digest For April 16
HIV Drugs for Alzheimer’s
There are no meaningful therapies to treat Alzheimer’s, the mind robbing disease which impacts nearly 7 million people in the U.S.
Now scientists, writing in the Journal Pharmaceuticals, say they …
-
Labcorp introduces GFAP test, a critical blood─based biomarker for early detection of neurodegenerative diseases and neurological injuries
16 Apr 2024 07:37 GMT
Labcorp, a global leader of innovative and comprehensive laboratory services, announced the availability of the nation's first test for glial fibrillary acidic protein (GFAP), a critical blood-based biomarker for the early detection of …
-
Roche, Eli Lilly Alzheimer's blood test granted breakthrough device designation
15 Apr 2024 21:48 GMT
-
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial
15 Apr 2024 15:06 GMT
Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease
Enrolment in XanaCIDD phase 2a trial of cognitive …